Controversies in Diagnosis and Management of Breast Borderline Lesions

Call for Papers

Breast borderline lesions or high-risk breast lesions include multiple lesions often diagnosed when imaging findings are sampled using a needle biopsy. Advances in breast-imaging and image-guided percutaneous needle biopsies have been associated with an increase in the identification and report of such lesions. Physicians from different disciplines may encounter such lesions not infrequently.

We invite investigators to contribute original research articles as well as review articles on the different breast borderline or high-risk lesions, their diagnosis, and management. Potential topics include, but are not limited to:

• Specific lesions: columnar cell lesions, apocrine lesions, mucinous lesions, papillomas and papillomatosis, atypical ductal hyperplasia, fibroepithelial lesions, lobular lesions, precursor lesions in males, and precursor lesions in hereditary patients
• Imaging findings
• Factors that impact upgrade to cancer on excision of different high-risk lesions
• Pathological findings
• Genetic alterations
• Risk reduction management
• Epidemiology of high-risk lesions

Before submission authors should carefully read over the journal's Author Guidelines, which are located at http://www.hindawi.com/journals/ijbc/guidelines/. Prospective authors should submit an electronic copy of their complete manuscript through the journal Manuscript Tracking System at http://mts.hindawi.com/submit/journals/ijbc/cdmbl/ according to the following timetable:

Lead Guest Editor

• Tehillah S. Menes, Department of Surgery, Tel Aviv Sourasky Medical center, Tel Aviv, Israel

Guest Editors

• Paul J. van Diest, Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands
• Shabnam Jaffer, Department of Pathology, Mount Sinai Medical Center, New York, NY, USA